Comparative Pharmacology
Head-to-head clinical analysis: CONSTULOSE versus PEG LYTE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CONSTULOSE versus PEG LYTE.
CONSTULOSE vs PEG-LYTE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Lactulose is a synthetic disaccharide that is not absorbed in the small intestine. In the colon, it is metabolized by bacteria to short-chain fatty acids, leading to an osmotic effect that draws water into the bowel, thereby softening stools and increasing bowel motility. In hepatic encephalopathy, lactulose acidifies the colonic environment, promoting the conversion of ammonia (NH3) to ammonium (NH4+), which is trapped and excreted in feces.
PEG-LYTE is an osmotic laxative that induces diarrhea by retaining water in the colon through the non-absorbable polyethylene glycol (PEG) and electrolytes, which prevent dehydration and electrolyte imbalance during bowel cleansing.
10-20 g (15-30 mL) orally once daily, increased to 30-45 g (45-60 mL) if needed; or 30-45 g (45-60 mL) orally every 6-8 hours for hepatic encephalopathy.
4 liters orally as a single dose or in divided doses for colonoscopy preparation.
None Documented
None Documented
Not applicable due to minimal systemic absorption; local action in colon. In cases of systemic absorption, half-life is not clinically relevant.
Not applicable; PEG-3350 is minimally absorbed (<0.06%), thus systemic half-life is not clinically relevant. Local gut transit time ~1-2 hours.
Primarily fecal (unchanged); minimal systemic absorption (<3%), thus negligible renal excretion.
Primarily fecal (98-99%) as unchanged polyethylene glycol (PEG) 3350; negligible renal excretion (<0.2%). Electrolytes (sodium, potassium, bicarbonate) are partially absorbed and excreted renally.
Category C
Category C
Osmotic Laxative
Osmotic Laxative